Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype.

STUDY OBJECTIVES Inducible nitric oxide synthase (iNOS) is upregulated in a number of inflammatory lung conditions, and exhaled nitric oxide (NO) concentration is increased. However, previous studies in children with cystic fibrosis (CF) have shown that exhaled NO is reduced. The purpose of this investigation was to study exhaled NO concentration in adults with CF, and to investigate the effect of CF genotype and respiratory tract infection on this measurement. DESIGN Exhaled and nasal NO levels were measured in 54 adult CF subjects and 37 healthy nonsmoking age-matched subjects using a chemiluminesence analyzer. Spirometry (FEV(1) and FVC), CF genotype, and bacterial colonization were also recorded. SETTING This study was conducted at a national CF center. RESULTS The mean age of patients was 26.9 years, and the mean FEV(1) was 50.5% predicted (range, 17 to 104%). Nasal NO in the CF patients (mean, 520 parts per billion [ppb]; confidence interval [CI], 452 to 588) was significantly lower (p < 0.001) than in control subjects (987 ppb; CI, 959 to 1,015). Exhaled NO was significantly lower (p < 0. 001) in CF patients (5.0 ppb; CI, 4.1 to 6.1) than in control subjects (7.3 ppb; CI, 6.8 to 7.8). FEV(1) did not correlate with nasal or exhaled NO. No association was observed between genotype and NO values or colonization with Pseudomonas aeruginosa. CONCLUSIONS Despite the airway inflammation that is characteristic of CF, both nasal and exhaled NO were reduced. There was no association with genotype or infection status. As NO has bacteriostatic effects and may augment mucociliary clearance, this observation may be of clinical importance.

[1]  A. Nicholson,et al.  The pathology of cystic fibrosis , 2002 .

[2]  M. Drumm,et al.  Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. , 1998, The Journal of clinical investigation.

[3]  B. Rubin,et al.  Nitric oxide metabolites in cystic fibrosis lung disease , 1998, Archives of disease in childhood.

[4]  M. Ub.  LACK OF INDUCIBLE NITRIC OXIDE SYNTHASE IN BRONCHIAL EPITHELIUM: A POSSIBLE MECHANISM OF SUSCEPTIBILITY TO INFECTION IN CYSTIC FIBROSIS , 1998 .

[5]  A. Aljada,et al.  Nitric oxide synthase. , 1998, Methods in molecular biology.

[6]  F. Ratjen,et al.  Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis , 1997, Pediatric pulmonology.

[7]  A. Bush,et al.  Is nitric oxide in exhaled air produced at airway or alveolar level? , 1997, The European respiratory journal.

[8]  N. Van Rooijen,et al.  Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling. , 1997, Journal of immunology.

[9]  S. Durham,et al.  Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. , 1997, The Journal of allergy and clinical immunology.

[10]  J. Dötsch,et al.  Airway nitric oxide in asthmatic children and patients with cystic fibrosis. , 1996, The European respiratory journal.

[11]  E. Weitzberg,et al.  Exhaled nitric oxide in paediatric asthma and cystic fibrosis. , 1996, Archives of disease in childhood.

[12]  R. Dinwiddie,et al.  Reduced upper airway nitric oxide in cystic fibrosis. , 1996, Archives of disease in childhood.

[13]  M. Konstan,et al.  Inflammatory cytokines in cystic fibrosis lungs. , 1995, American journal of respiratory and critical care medicine.

[14]  M. Belvisi,et al.  Nitric oxide synthase activity is elevated in inflammatory lung disease in humans. , 1995, European journal of pharmacology.

[15]  M. Weinberger,et al.  The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis , 1995, Pediatric pulmonology.

[16]  J. Sisson,et al.  TNF-alpha and IL-1 beta upregulate nitric oxide-dependent ciliary motility in bovine airway epithelium. , 1995, The American journal of physiology.

[17]  D M Hansell,et al.  Elevated levels of exhaled nitric oxide in bronchiectasis. , 1995, American journal of respiratory and critical care medicine.

[18]  P. Ward,et al.  Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. , 1995, American journal of respiratory cell and molecular biology.

[19]  D. Riches,et al.  Early pulmonary inflammation in infants with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.

[20]  T. Hökfelt,et al.  High nitric oxide production in human paranasal sinuses , 1995, Nature Medicine.

[21]  T. Higenbottam,et al.  Exhaled nitric oxide in isolated pig lungs. , 1995, Journal of applied physiology.

[22]  J. Stamler,et al.  Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Nathan,et al.  Regulation of biosynthesis of nitric oxide. , 1994, The Journal of biological chemistry.

[24]  J. Stamler,et al.  The biology of nitrogen oxides in the airways. , 1994, American journal of respiratory and critical care medicine.

[25]  P. J. Barnes,et al.  Increased nitric oxide in exhaled air of asthmatic patients , 1994, The Lancet.

[26]  P. Howarth,et al.  Induction of nitric oxide synthase in asthma , 1993, The Lancet.

[27]  N. Wiklund,et al.  Endogenous nitric oxide in single exhalations and the change during exercise. , 1993, The American review of respiratory disease.

[28]  J. Stamler,et al.  Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. , 1993, American journal of respiratory cell and molecular biology.

[29]  E. Weitzberg,et al.  Increased amount of nitric oxide in exhaled air of asthmatics. , 1993, The European respiratory journal.

[30]  P. Jorens,et al.  Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. , 1993, The American journal of physiology.

[31]  S Moncada,et al.  Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. , 1991, Biochemical and biophysical research communications.

[32]  F. Murad,et al.  Isoforms of nitric oxide synthase. Characterization and purification from different cell types. , 1991, Biochemical pharmacology.

[33]  M. Berger.  Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good? , 1991, Clinical reviews in allergy.

[34]  S. Douglas,et al.  Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. , 1990, The American review of respiratory disease.

[35]  G. Taylor,et al.  Nitric oxide is inactivated by the bacterial pigment pyocyanin. , 1990, The Biochemical journal.

[36]  M. McPherson,et al.  Defective phosphorylation of a calmodulin-binding protein in cystic-fibrosis submandibular glands. , 1989, The Biochemical journal.

[37]  L. Tsui,et al.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. , 1989, Science.

[38]  C. McKay,et al.  Effects of nitric oxide and nitrogen dioxide on bacterial growth , 1983, Applied and environmental microbiology.

[39]  H. Joos,et al.  PARANASAL SINUSES IN CYSTIC FIBROSIS. INCIDENCE OF ROENTGEN ABNORMALITIES. , 1964, American journal of diseases of children.